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Abstract
Background: Since a male-related higher cardiovascular morbidity and mortality in patients with Chagas’ heart
disease has been reported, we aimed to investigate gender differences in myocardial damage assessed by
cardiovascular magnetic resonance (CMR).
Methods and results: Retrospectively, 62 seropositive Chagas’ heart disease patients referred to CMR (1.5 T) and
with low probability of having significant coronary artery disease were included in this analysis. Amongst both
sexes, there was a strong negative correlation between LV ejection fraction and myocardial fibrosis (male r = 0.64,
female r = 0.73, both P < 0.001), with males showing significantly greater myocardial fibrosis (P = 0.002) and lower LV
ejection fraction (P < 0.001) than females. After adjustment for potential confounders, gender remained associated
with myocardial dysfunction, and 53% of the effect was mediated by myocardial fibrosis (P for mediation = 0.004).
Also, the transmural pattern was more prevalent among male patients (23.7 vs. 9.9%, P < 0.001) as well as the
myocardial heterogeneity or gray zone (2.2 vs. 1.3 g, P = 0.003).
Conclusions: We observed gender-related differences in myocardial damage assessed by CMR in patients with
Chagas’ heart disease. As myocardial fibrosis and myocardial dysfunction are associated to cardiovascular outcomes,
our findings might help to understand the poorer prognosis observed in males in Chagas’ disease.
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Background
Considered a neglected tropical disease, Chagas’ disease
is caused by a protozoan parasite, Trypanosoma cruzi (T.
cruzi) and has recently become a global health concern
[1], due to immigration from endemic areas into the
developed world [2, 3]. In Latin America, Chagas’ heart
disease is still a major cause of heart failure despite a
drop in incidence in the last decades [4].
Patients with Chagas’ heart disease have a poorer
prognosis in comparison to other cardiomyopathies and,
in particular, male gender has been associated to a
higher mortality rates [5]. The reasons for this worse clin-
ical prognosis remain unclear and, to our knowledge,
there is a lack of studies about sex-related differences in
myocardial damage in patients with Chagas’ heart disease.
Cardiovascular magnetic resonance (CMR) is able to
assess the extent of the myocardial fibrosis (MF), which
correlates to LV ejection fraction (LVEF) and is a marker
of disease severity in Chagas’ heart disease [6, 7]. We
sought to investigate whether the male gender is associ-
ated to greater myocardial damage assessed by CMR.
Methods
From 2 previous studies [6, 8], 62 adults with chronic
Chagas’ disease followed at Heart Institute (InCor), re-
ferred to CMR, from 2004 to 2012 and with low prob-
ability of having severe coronary artery disease (CAD)
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[9] were included in the study. We used a validated
high-risk CAD score [9] based on the following clinical
characteristics recorded at the time of CMR: age (−1 to
10 points), male sex (3 points), diabetes (2 points),
hypertension (1 point), current smoking (2 points),
hypercholesterolemia (1 point), family history of CAD (2
points), history of peripheral vascular disease (2 points),
and chest pain symptoms (0–2 points). Patients who
scored ≥18 points were excluded. Other exclusion cri-
teria were previous myocardial infarction and severe
valve disease. Patients in whom oral transmission from
outbreaks of either beverage or food contaminations was
suspected - which has unfortunately emerged in Brazil
[10] - were not included in our study. The reason for
this exclusion was the potentially more severe course of
the disease following oral transmission [11]. The study
was approved by the institutional review board for
human subject studies, and all patients provided written
informed consent.
CMR
CMR was performed with a 1.5 T GE CV/i CMR System
(Wakeusha Wisconsin). Ventricular function, volumes
and mass were obtained from at least 10 short-axis
ventricular slices, imaged with a steady state free pre-
cession pulse sequence, covering the entire left ven-
tricle. Late gadolinium enhancement (LGE) images
were acquired 10–20min after an intravenous bolus of
0.2 mmol/kg of gadolinium-based contrast, with an
inversion-prepared gradient echo-sequence. The se-
quence parameters for cine/LGE imaging were,
respectively: repetition time 3.9/7.1 ms, echo time
1.7/3.1 ms, flip angle 45°/20°, cardiac phases 20/1,
views per segment 8/16 to 32, matrix 256 × 128/256 ×
192, slice thickness 8/8 mm, gap between slices 2/
2 mm and field of view 32 to 38/32 to 38 cm,
inversion time none/150 to 250 ms, receiver band-
width 125/31.25 kHz, number of excitations 1/1, ac-
quisition every heart beat/every-other heart beat.
Data analysis
All CMR images were analyzed with the CVI42 software
(Circle Cardiovascular Imaging Inc. Calgary, Canada) by a
trained observer. End-systolic, end-diastolic LV volumes,
LV mass and LV ejection fraction were measured by
standard methods [12]. For quantification of myocardial
fibrosis (MF), we applied a semiautomatic thresholding
technique to the LGE images with a signal intensity (SI)
cutoff value of mean + 6 standard deviation (SD) (MF: SI ≥
meanSI of normal myocardium+ 6 standard deviation of
normal myocardium), which had best agreement with
visual analysis. The location and extent of MF were
assessed using the American Heart Association (AHA)
segment model. Additionally, the pattern of LGE was
classified as subendocardial, midwall, subepicardial or
transmural. The myocardial heterogeneity or gray zone
extent was defined as the myocardial region with pixels SI
between meanSI + 6SD and meanSI + 7SD [13–15].
Statistical analysis
Chi-squared or Fisher-exact tests and two-sample t-tests
or Wilcoxon rank sum test for categorical or continuous
data, respectively, were performed for comparing baseline
characteristics across gender groups. The correlation
between MF and LVEF was performed by Spearman’s test.
We assumed that MF lies on the causal pathway
between gender and myocardial dysfunction in
Chagas’ disease, as a mediator variable and we tested
the following mediation assumptions [16]: gender has
a significant effect on MF; gender has a significant ef-
fect on LVEF in the absence of the MF; MF has a sig-
nificant unique effect on LVEF; and the effect of the
gender on LVEF shrinks when the MF is added to the
model. A Sobel-Goodman test was used to assess
whether the amount of mediation effect was statisti-
cally significant [17]. After confirming the mediation
assumptions, MF was added to the final model and a
multivariate linear regression analysis was performed
to determine the effect of gender on LVEF adjusted
possible confounders. For all univariate and multivari-
ate analysis, we used MF assessed as % LV mass since
the normal population males have significantly greater
myocardial mass [18].
All statistical analyses were performed with Stata
13.0 (StataCorp, Texas, USA) and a P-value < 0.05 was
considered as statistically significant and all reported
P-values were two-tailed.
Results
Clinical characteristics and ventricular remodeling
Patient characteristics are shown in Table 1. In com-
parison with 38 females (61.3%), 24 males (38.7%)
had similar mean age (54 ± 11 vs. 55 ± 11, P = 0.55) as
well as relative low prevalence of CAD risk factors.
Although higher in males, both gender groups had
low mean high-risk CAD score (4.3 ± 1.7 vs. 1.1 ± 1.1,
P < 0.001). Moreover, 35 of our patients (56%) had
either an invasive or coronary computed tomographic
(CT) angiography during their follow-up and none of
them had obstructive CAD.
Heart failure symptoms were significantly more frequent
and severe among male patients (54% vs. 29% New York
Heart Association [NYHA] class > 1, P = 0.04). Addition-
ally, LV and RV remodeling was more pronounced in male
than female patients, with males presenting significantly
higher LV/RV dilation, LV mass and lower LV/RV ejection
fraction than females.
Assunção et al. Journal of Cardiovascular Magnetic Resonance  (2016) 18:88 Page 2 of 8
Myocardial fibrosis: presence, extent, distribution and
patterns
Most of patients had MF (77%) and MF was similarly fre-
quent in male and female patients (87% vs. 71%, P = 0.21)
(Table 1). The distribution of MF in males and females
was similarly frequent in the lateral and inferior LV seg-
ments, but significantly different in the septal (basal ante-
rosseptal, P = 0.004) and apical segments (anterior and
inferior apical, both P = 0.03) (Fig. 1). The amount of MF
was significantly higher in male patients than in females
(median 19.0 vs. 2.4 g, P < 0.001, and % LV mass 12 vs.
3%, P = 0.003) (Table 1).
Although LGE patterns indistinguishable from CAD were
found in 23.1% of LV segments of patients (n = 151/992
transmural, n = 78/992 subendocardial), non-ischemic
patterns were frequently and concomitantly observed
(mean > 3 types of LGE patterns). Only 30% patients had
subendocardial and/or transmural patterns and did not
undergo any angiography during follow-up. Interestingly,
these potentially ischemic patterns were also found in
24.6% of LV segments (n = 138/560) of those patients who
had angiography (Fig. 2). Compared to females, males had
more frequently transmural (23.6 vs. 9.9%, P < 0.001), sube-
picardial (14.1 vs. 9.2%, P = 0.02) and midwall patterns (23.8
vs. 15%, P < 0.001) (Fig. 3). Likewise, gray zone extent was
higher in males (median 2.2 vs. 1.3 g, P = 0.003) (Table 1).
Extent of myocardial fibrosis and LV remodeling
For all patients, MF (%LV Mass) was negatively corre-
lated with LVEF (r = −0.75, P < 0.001) and this relation-
ship was comparably strong among males (r = −0.64, P <
0.001) and females (r = −0.73, P < 0.001), with no indica-
tion of an effect modification by gender (P-value for
interaction = 0.35) (Fig. 4).
Table 1 Characteristics of Patients with Chagas’ Heart Disease
Characteristics Male (n = 24) Female (n = 38) P-value
Clinical Data
Age – years* 54 (11) 55 (11) 0.55
Body mass index [kg/m2]† 26 (23–29) 25 (24–29) 0.55
Obesity - no. (%) 5 (21) 9 (24) 0.79
Hypercholesterolemia – no. (%) 9 (38) 16 (42) 0.72
Diabetes mellitus – no. (%) 4 (17) 2 (5) 0.19
Hypertension – no. (%) 8 (33) 14 (37) 0.78
Current smoker – no. (%) 4 (17) 2 (5) 0.19
CAD score† 4.3 (1.7) 1.1 (1.1) <0.001
NYHA functional class > I - no. (%) 13 (54) 11 (29) 0.04
NYHA functional class† 2 (1–2.5) 1 (1–2) 0.02
GFR [mL/min per 1.73 m2]* 80 (26) 78 (26) 0.73
CMR
LVEDVI [mL/m2]† 116 (97–161) 86 (72–108) <0.001
LVESVI [mL/m2]† 74 (50–114) 34 (28–57) <0.001
LV mass index [g/m2]† 74 (63–89) 51 (44–61) <0.001
LVEF [%]† 37 (28–46) 58 (47–62) <0.001
Aneurysm – no. (%) 7 (29) 6 (16) 0.21
RVESVI [mL/m2]† 80 (63–92) 68 (59–74) 0.016
RVEDVI [mL/m2]† 38 (32–50) 25 (22–34) <0.001
RVEF [%]† 50 (36–59) 60 (52–65) 0.005
Myocardial Fibrosis – yes 21 (87) 27 (71) 0.21
Myocardial Fibrosis [grams]† 19 (9–30) 2.4 (0–12) <0.001
Myocardial Fibrosis (% LV mass)† 12 (8–22) 3 (0–11) 0.003
Gray zone 6SD-7SD [grams]† 2.2 (0–4.2) 1.3 (0–2.3) 0.003
LGE Patterns* 3.9 (0.9) 3.8 (1.0) 0.72
LV denotes left ventricular, LVEF left ventricular ejection fraction, LVEDVI left ventricular end-diastolic volume index, LVESVI left ventricular end-systolic volume
index, NYHA New York Heart Association Functional Classification, RVEF right ventricular ejection fraction, RVEDVI right ventricular end-diastolic volume index,
and RVESVI right ventricular end-systolic volume index, LGE late gadolinium enhancement, GFR Glomerular filtration rate. CAD score to assess the clinical
probability of having high-risk CAD (low ≤7 points; intermediate, 8–17 points. Patients with high score, ≥18 points, were excluded from this study) [9].
*means (SD) and †medians (25 and 75th centiles). Significant P-values (< 0.05) are shown in bold
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Fig. 2 Examples of CMR, invasive and CT angiography in two representative patients with Chagas’ heart disease. First patient (top row): a and b CMR
reveals transmural LGE pattern in the LV lateral wall (yellow arrow) with concomitant septal midwall LGE (white arrow) and, by invasive angiography,
(c and d) normal coronary arteries. Second patient (bottom row): (e) cine-CMR image reveals a classical Chagas’ heart disease finding, the vorticle
aneurysm (red arrow), (f and g) LGE reveals subendocardial pattern in the lateral wall (yellow arrow) and, by CT angiography, (h and i) normal coronary
arteries. Blue arrow (f and g) indicating the region of interest (ROI) for calculating the mean signal intensity (SI) of the reference normal myocardium
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Male gender was associated with 165% higher mean
MF (95% confidence interval [CI] 11 to 320%) and
30% lower mean LVEF (95% CI 18–43%) compared to
female (Fig. 5) in the unadjusted analysis. Although
attenuated, the effect of gender on LVEF remained
significant (P = 0.02) when MF was added as predictor
in the model. In the mediation analysis (Figs. 5 and
6), approximately 53% of the total effect of gender on
LVEF was mediated by MF (P-value for mediation
analysis = 0.004). In a multivariate model to adjust for
CAD risk factors, gender remained associated with
myocardial dysfunction (Fig. 4).
Discussion
In this study, we observed sex-related differences in
myocardial damage assessed by CMR in patients with
Chagas’ heart disease: males had significantly more ad-
verse ventricular remodeling and greater MF, as well as
different LGE patterns in comparison with females.
Moreover, male gender was independently associated
with reduced myocardial function and this effect was
mostly mediated by MF. These findings might help to
understand the observed gender-related differences in
the pathogenesis of chronic Chagas’ heart disease.
Clinical data have revealed higher mortality among male
patients with Chagas’ heart disease [5, 19], but this is the
first study to demonstrate a significantly higher degree of
myocardial damage in vivo. In our study, males patients
had lower LVEF by 30% and higher MF by 165% on
average compared to females. The pathogenesis of chronic
Chagas’ heart disease is complex, but the inflammatory
process with autoimmune reaction is considered the
main pathway for myocardial damage, increasing MF,
adverse left ventricular remodeling and heart failure se-
verity [20–23]. In mouse models, this immune re-
sponse against T. cruzi infection was more unfavorable
in male species, and linked to gonadal hormone differ-
ences [24, 25]. MF measured by CMR is a key marker of
myocardial damage in non-ischemic cardiomyopathies
[26–28] and, likewise, in Chagas’ heart disease [6, 8]. For
our patients, we found that the association between
gender and LVEF was mediated by the amount of MF
(53% of the effect was mediated). Hence, we hypothesized
Fig. 3 LGE patterns in male and female patients with Chagas’ heart
disease. “n” illustrates the absolute frequency of the LGE pattern
divided by the total of analyzed segments
Fig. 4 Sex-specific correlations between MF and LVEF
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that male hormone differences might be an exposure to
greater myocardial dysfunction in Chagas’ pathogenic,
being the amount of MF a partly causal pathway.
Furthermore, the presence, size and heterogeneity of
MF assessed by CMR have been described as independent
predictors for death in ischemic and non-ischemic cardio-
myopathies [29–31]. Besides the greater MF amount, we
observed the transmural pattern of MF more frequently in
males than females (23.7 vs. 9.9%, P < 0.001), as well as
higher extent of the gray zones. Interestingly, the trans-
mural pattern has been identified as independent pre-
dictor to ventricular tachycardia (4.1-fold greater) in
Chagas’ heart disease [32]. A higher myocardial hetero-
geneity and/or larger gray zone extent have also been
Fig. 5 a Unadjusted effect of gender on MF and b effects of gender and MF (10-unit increase) on LVEF. Model 1 demonstrates unadjusted effects
of gender and MF on LVEF. Model 2 demonstrates the effect of gender on LVEF when adjusted to MF. Model 3 demonstrates the Model 2
additionally adjusted for CAD risk factors (age, diabetes mellitus, hypertension, hypercholesterolemia, body mass index, active smoking). Natural
logarithm transformation was used to improve normality and/or homoscedasticity of residuals. The effect was calculated from exponential linear
regression coefficients (100 × [eβ − 1]). LVEF was defined as left ventricular ejection fraction, and MF myocardial fibrosis (%LV Mass)
Fig. 6 Mediation model illustrating indirect effect (through MF) and direct effect of gender on LVEF. β-coefficients of log-level linear regressions
of Sobel-Goodman mediation tests. LVEF was defined as left ventricular ejection fraction, and MF myocardial fibrosis (%LV Mass)
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associated with a higher frequency of adverse cardiac
events in non-ischemic cardiomyopathies [33].
There are several limitations in this study. First, although
ventricular remodeling and MF have been linked to worse
clinical prognosis, this study was not designed to investigate
cardiac outcomes. Secondly, as this was a cross-sectional
study in Chagas’ disease, the time of disease onset remained
undetermined, and duration of exposure could influence
myocardial damage. However, children aged <5 years are
most likely to be infected in domiciliary vector transmission
(by far, the most common mode of transmission in Brazil
in the past) [1, 34], and the number of new cases of Chagas’
disease have dramatically been decreasing in Brazil since
1990 [1]. Consequently, our male and female patients, who
were not different in age at the moment of CMR, may have
similar exposure times. Thirdly, we recognize that as the
patients have been followed at a tertiary hospital and
current guidelines in Brazil do not recommend that
patients with Chagas’ disease routinely undergo CMR, our
results may not apply to other clinical settings and may suf-
fer from some referral bias. Lastly, we did not assess the
possible association between hormones and myocardial
damage. Therefore our findings should be considered as
hypothesis-generating for future studies adequately de-
signed for addressing these issues.
Conclusions
Our study demonstrated for first time gender-specific dif-
ferences in myocardial damage in Chagas’ heart disease by
CMR. Male gender was associated with a higher amount
of myocardial fibrosis and worse ventricular remodeling.
The relationship of these findings with clinical outcomes
in Chagas’ heart disease warrants further investigation.
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